Assessing Varied Orthobiologics Treatment Protocols and Bioformulations for Varied Pathoanatomic Diagnoses of the Knee
Peter A. Everts, PhD FRSM
This Circle, comprised of expert orthobiologics practitioners and scientists, is designed to help track, benchmark, and standardize an evidence-based approach to orthobiologics dosing, formulations, and delivery for a variety of pathoanatomic of knee indications.
Observational, Longitudinal, Quality Improvement
Join other interventional practitioners in the utilization and benchmarking of practice-specific bioformulations and injection protocols for various knee indications.
- Knee Assessment Survey
Demographics, IKDC, WOMAC, VAS - Patient Information Survey for the Clinician
Specific Pathoanatomic Diagnoses - Intervention Information Survey for the Clinician
Bioformulations, HCT/P Characterization, Injection Location and Dosage
Private Circle
Assessing Varied Orthobiologics Treatment Protocols and Bioformulations for Varied Pathoanatomic Diagnoses of the Knee
This Circle, comprised of expert orthobiologics practitioners and scientists, is designed to help track, benchmark, and standardize an evidence-based approach to orthobiologics dosing, formulations, and delivery for a variety of pathoanatomic of knee indications.
Burden-free data collection for various knee related pathologies in order to optimize effective and safe orthobiological applications.
VAS, WOMAC, IKDC
PRP; BMAC; MFAT
Join other interventional practitioners in the utilization and benchmarking of practice-specific bioformulations and injection protocols for various knee indications.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
Private Circle
CIRCLE LIBRARY
CIRCLE NAME
Total Knee Arthroplasty Outcome-Based Performance Measure
SURVEYS
VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)
As specified by Provider
THIS CIRCLE IS FOR:
Provider Receiving CMS Reimbursement For TKAs
CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.
Other Providers Performing TKAs
Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.
WHY CIRCLES
If you have any questions, please contact us.